Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ROBERT ANG Insider Profile
4 Followers
ROBERT ANG, Chief Business Officer at Neon Therapeutics, holds 787.49K shares in Vor Biopharma (Ticker: VOR), holds 279.52K shares in Neon Therapeutics (Ticker: NTGN).
ROBERT ANG Neon Therapeutics (NTGN)Chief Business Officer
Neon Therapeutics (NTGN)
Chief Business Officer
Not Ranked
ROBERT ANG has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that ROBERT ANG holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by ROBERT ANG
ROBERT ANG's Trading History
Neon Therapeutics
Mar 01, 2019
―
Uninformative Buy
―
$858.14K
Vor Biopharma
Nov 08, 2024
President & CEO, Director
Uninformative Sell
2.03K
$682.75K
List of latest transactions for each holding click on a transaction to see ROBERT ANG's performance on stock
You May Also Like
ROBERT ANG insider profile FAQ
What is the percentage of profitable transactions made by ROBERT ANG?
The percentage of profitable transactions made by ROBERT ANG is ―.
What is the average return per transaction made by ROBERT ANG?
The average return per transaction made by ROBERT ANG is ―.
What stocks does ROBERT ANG hold?
ROBERT ANG holds: NTGN, VOR stocks.
What was ROBERT ANG’s latest transaction?
ROBERT ANG latest transaction was an Uninformative Sell of $2.03K.
What was ROBERT ANG's most profitable transaction?
ROBERT ANG’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is ROBERT ANG's role in Neon Therapeutics?
ROBERT ANG's role in Neon Therapeutics is Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.